Position in ABCL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,518,063
-$1,547,440 QoQ
Shares Held
1,294,574
-27.0% QoQ
Ownership
0.424%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 138 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Derivatives in ABCL
reported options exposure · as of Sep 30, 2023CallValue
$1,150,000
CallShares
250,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,466,124,984 across 340 Biotechnology names. ABCL ranks #183 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ABCL
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,518,063 | 1,294,574 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,065,503 | 1,773,539 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,221,572 | 2,429,736 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,653,730 | 3,397,589 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,939,451 | 869,709 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,344,354 | 1,482,715 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,960,106 | 753,887 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,334,042 | 450,690 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,744,121 | 1,268,018 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,167,300 | 1,255,219 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,997,883 | 1,521,279 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $1,150,000 | 250,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $21,108,812 | 3,267,618 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,262,000 | 300,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $9,098,502 | 1,206,698 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,331,061 | 427,548 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $1,629,917 | 160,900 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $8,597,416 | 869,304 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $2,967,000 | 300,000 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $3,165,180 | 297,200 | Put | Sole | 2022-08-15 | |
| 2022-06-30 | $31,488,258 | 2,956,644 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $14,566,461 | 1,493,996 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,957,962 | 696,361 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,990,292 | 847,819 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,444,454 | 65,657 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $828,216 | 24,388 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,885,413 | 96,556 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||